Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, et al.

Contemp Clin Trials. 2016 Sep; 50:166-77. Epub 2016 Aug 10. PMID: 27521810. Abstract